Spots Global Cancer Trial Database for braf mutated
Every month we try and update this database with for braf mutated cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma | NCT04722575 | Melanoma | Cobimetinib 20 ... Vemurafenib 240... Atezolizumab 12... | 18 Years - | Fondazione Melanoma Onlus | |
Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma | NCT04722575 | Melanoma | Cobimetinib 20 ... Vemurafenib 240... Atezolizumab 12... | 18 Years - | Fondazione Melanoma Onlus | |
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer | NCT01709292 | Thyroid Cancer | Vemurafenib (Al... Vemurafenib (Po... Post Surgery - ... | 18 Years - | M.D. Anderson Cancer Center | |
Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer | NCT01709292 | Thyroid Cancer | Vemurafenib (Al... Vemurafenib (Po... Post Surgery - ... | 18 Years - | M.D. Anderson Cancer Center |